(IN BRIEF) Almirall, a leading biopharmaceutical company specializing in medical dermatology, has reported its full-year 2023 financial results, showcasing a…
(IN BRIEF) Almirall S.A., a leading pharmaceutical company specializing in medical dermatology, has finalized an exclusive license agreement with Novo…
Nanostructured biomaterial for wound dressings and dermatology to be integrated into Health Care business Evonik Venture Capital’s early investment in…
(PRESS RELEASE) KORTRIJK, 23-Mar-2021 — /EuropaWire/ — Barco announces partnership with Modernizing Medicine for the interface of its Demetra digital…
These collaborations are in response to the calls for innovation via AlmirallShare, the open innovation platform of Almirall and aim…
Attractive portfolio with strong and successful models of the human skin Global dissemination of regulatory approved alternative test methods Important…
The first Rhenium-SCT® treatment was accomplished by the interregional professional association for nuclear medicine in Hanau (PRESS RELEASE) HANAU, Germany,…
New recognition of OncoBeta’s success in developing and providing an innovative therapy for non-melanoma skin cancer patients. (PRESS RELEASE) Pasadena,…
The interregional professional association for nuclear medicine in Hanau is the first treatment center in Germany offering Rhenium-SCT® for the…
LJUBLJANA, Slovenia, 21-Sep-2018 — /EuropaWire/ — The latest study published in the World Journal of Urology (Comparison between erbium‑doped yttrium…
Sandoz is seeking approval of biosimilar infliximab for use in all indications of its reference medicine across gastroenterology, rheumatology and…
Omalizumab met all primary and secondary endpoints in pivotal GLACIAL study of patients with refractory chronic spontaneous urticaria (CSU)[1] Omalizumab…